Key result
Plasma proteomic analysis identified 117 differentially expressed proteins in AMI patients with heart failure compared to those without, highlighting the involvement of the NF-κB signaling pathway.
Why the study?
The pathogenesis of disease progression targets for patients with heart failure after acute myocardial infarction was investigated using plasma proteomics.
Does plasma proteomic analysis identify differentially expressed proteins in AMI patients with heart failure compared to those without?
Cross-Sectional (n=20)
No
Does plasma proteomic analysis identify differentially expressed proteins in AMI patients with heart failure compared to those without?
p-value: p=<0.05
Plasma proteomics identified 14 proteins associated with the NF-κB signaling pathway that are highly expressed in patients developing heart failure after acute myocardial infarction, providing potential novel biomarkers for diagnosis and pathogenesis.
NF-κB-related proteins may aid post-MI HF risk stratification; hypothesis-generating for pathogenesis pending larger validation studies.
Aims: The pathogenesis of disease progression targets for patients with heart failure after acute myocardial infarction was investigated by using plasma proteomics. Methods: The plasma proteomes of acute myocardial infarction patients with (MI-HF) and without (MI-WHF) heart failure were compared. Each group consisted of 10 patients who were matched for age and sex. The peptides were analyzed by 2-dimensional liquid chromatography coupled to tandem mass spectrometry in a high definition mode. Parallel reaction monitoring (PRM) verified the selected target proteins. Results: We identified and quantified 2,589 and 2,222 proteins, respectively, and found 117 differentially expressed proteins (DEPs) (≥1.5-fold), when the MI-HF and MI-WHF groups were compared. Of these 51 and 66 were significantly up-regulated and down-regulated, respectively. The significant DEPs was subjected to protein-protein interaction network analysis which revealed a central role of the NF-κB signaling pathway in the MI-HF patients. PRM verified that MB, DIAPH1, VNN1, GOT2, SLC4A1, CRP, CKM, SOD3, F7, DLD, PGAM2, GOT1, UBA7 and HYOU1 were 14 proteins which were highly expressed in MI-HF patients. Conclusions: These findings showed a group of proteins related to the NF-κB signaling pathway in the pathogenesis of patients with poor outcomes after experiencing MI-HF. These proteins may be useful candidate markers for the diagnosis of MI-HF as well as help to elucidate the pathophysiology of this major cause of mortality in older patients.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) conducted a cross-sectional in Heart failure after acute myocardial infarction (n=20). Heart failure post-AMI vs. AMI without heart failure was evaluated on Differentially expressed proteins (DEPs) in plasma (p=<0.05). Plasma proteomic analysis identified 117 differentially expressed proteins in AMI patients with heart failure compared to those without, highlighting the involvement of the NF-κB signaling pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: